Abstract
To investigate the effectiveness of antimicrobial-coated sutures compared with non-coated sutures in reducing surgical site infection (SSI) and develop recommendations for World Health Organization (WHO) SSI prevention guidelines. We searched Medline, Embase, Cinahl, Cochrane Central Register of Controlled Trials, and WHO Global Health from 1990–16/02/2015 with language restricted to English, Spanish, and French. Meta-analysis was performed with a random-effects model. Meta-regression analysis assessed whether the effect of antimicrobial coating changed according to the type of suture and surgery. Subgroup analyses were based on types of sutures. Quality of the retrieved evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation. Thirteen randomized controlled trials (RCTs) and five observational studies (OBSs) met the inclusion criteria. Antimicrobial sutures significantly reduced SSI risk (for RCTs: OR 0.72, 95 % CI 0.59–0.88, p = 0.001, I2 = 14 %; for OBSs: OR 0.58, 95 % CI 0.40–0.83, p = 0.003, I2 = 22 %). Only Vicryl Plus vs Vicryl revealed consistent results in favor of antimicrobial sutures (for seven RCTs: OR 0.62, 95 % CI 0.44–0.88, p = 0.007, I2 = 3 %; for four OBSs: OR 0.58, 95 % CI 0.37–0.92, p = 0.02, I2 = 41 %). The effect of antimicrobial coating was similar between different suture, wound, and procedure types. Quality of RCT evidence was moderate, and OBS evidence was very low quality. Triclosan-coated sutures may reduce SSI risk. However, the available evidence is of moderate/low quality, and many studies had conflicts of interest.
Similar content being viewed by others
Change history
24 May 2018
In the original version of this article, reference citations found in Tables 2, 3, and 4 contain errors in linking. The correct tables are reproduced below.
References
Russell AD (2004) Whither triclosan? J Antimicrob Chemother 53:693–695. doi:10.1093/jac/dkh171
McMurry LM, Oethinger M, Levy SB (1998) Triclosan targets lipid synthesis. Nature 394:531–532. doi:10.1038/28970
Levy CW, Roujeinikova A, Sedelnikova S, Baker PJ, Stuitje AR, Slabas AR, Rice DW, Rafferty JB (1999) Molecular basis of triclosan activity. Nature 398:383–384. doi:10.1038/18803
Rothenburger S, Spangler D, Bhende S, Burkley D (2002) In vitro antimicrobial evaluation of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect 3(Suppl 1):S79–S87. doi:10.1089/sur.2002.3.s1-79
Storch ML, Rothenburger SJ, Jacinto G (2004) Experimental efficacy study of coated VICRYL plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. Surg Infect 5:281–288. doi:10.1089/sur.2004.5.281
Marco F, Vallez R, Gonzalez P, Ortega L, de la Lama J, Lopez-Duran L (2007) Study of the efficacy of coated Vicryl plus antibacterial suture in an animal model of orthopedic surgery. Surg Infect 8:359–365. doi:10.1089/sur.2006.013
Leaper D, Assadian O, Hubner NO, McBain A, Barbolt T, Rothenburger S, Wilson P (2011) Antimicrobial sutures and prevention of surgical site infection: assessment of the safety of the antiseptic triclosan. Int Wound J 8:556–566. doi:10.1111/j.1742-481X.2011.00841.x
European Commission Health & Consumer Protection DG. Scientific Committee on Consumer Products (SCCP). Opinion on Triclosan. 19th Plenary of 21 January 2009 [WWWdocument].URL http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_166.pdf; Brussels. Accessed 11 Aug 2010
Matl FD, Zlotnyk J, Obermeier A, Friess W, Vogt S, Buchner H, Schnabelrauch H, Stemberger A, Kuhn KD (2009) New anti-infective coatings of surgical sutures based on a combination of antiseptics and fatty acids. J Biomater Sci Polym Ed 20:1439–1449. doi:10.1163/092050609X12457418973107
Obermeier A, Schneider J, Wehner S, Matl FD, Schieker M, von Eisenhart-Rothe R, Stemberger A, Burgkart R (2014) Novel high efficient coatings for anti-microbial surgical sutures using chlorhexidine in fatty acid slow-release carrier systems. PLoS One 9, e101426. doi:10.1371/journal.pone.0101426
National Institute for Health and Clinical Excellence (2008) Surgical site infection: prevention and treatment of surgical site infection. National Institute for Health and Clinical Excellence. Clinical Guideline CG78 [WWW document]. URL www.nice.org.uk
Anderson DJ, Podgorny K, Berrios-Torres SI, Bratzler DW, Dellinger EP, Greene L, Nyquist AC, Saiman L, Yokoe DS, Maragakis LL, Kaye KS (2014) Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 35(Suppl 2):S66–S88
Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group, Cochrane Statistical Methods Group (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. doi:10.1136/bmj.d5928
Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. doi:10.1007/s10654-010-9491-z
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Schunemann HJ (2011) GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383–394. doi:10.1016/j.jclinepi.2010.04.026
Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64:401–406. doi:10.1016/j.jclinepi.2010.07.015
Okada N, Nakamura T, Ambo Y, Takada M, Nakamura F, Kishida A, Kashimura N (2014) Triclosan-coated abdominal closure sutures reduce the incidence of surgical site infections after pancreaticoduodenectomy. Surg Infect 15:305–309. doi:10.1089/sur.2012.170
Diener MK, Knebel P, Kieser M, Schüler P, Schiergens TS, Atanassov V, Neudecker J, Stein E, Thielemann H, Kunz R, Frankenberg M, Schernikau U, Bunse J, Jansen-Winkeln B, Partecke LI, Prechtl G, Pochhammer J, Bouchard R, Hodina R, Beckurts KT, Leiflner L, Lemmens HP, Kallinowski F, Thomusch O, Seehofer D, Simon T, Hyhlik-D¸rr A, Seiler CM, Hackert T, Reissfelder C, Hennig R, Doerr-Harim C, Klose C, Ulrich A, Büchler MW (2014) Effectiveness of triclosan-coated PDS Plus versus uncoated PDS II sutures for prevention of surgical site infection after abdominal wall closure: the randomised controlled PROUD trial. Lancet 384:142–152. doi:10.1016/S0140-6736(14)60238-5
Ueno M, Saito W, Yamagata M, Imura T, Inoue G, Nakazawa T, Takahira N, Uchida K, Fukahori N, Shimomura K, Takaso M (2013) Triclosan-coated sutures reduce wound infections after spinal surgery: a retrospective, nonrandomized, clinical study. Spine J 15:933–938. doi:10.1016/j.spinee.2013.06.046
Thimour-Bergstrom L, Roman-Emanuel C, Schersten H, Friberg O, Gudbjartsson T, Jeppsson A (2013) Triclosan-coated sutures reduce surgical site infection after open vein harvesting in coronary artery bypass grafting patients: a randomized controlled trial. Eur J Cardiothorac Surg 44:931–938. doi:10.1093/ejcts/ezt063
Nakamura T, Kashimura N, Noji T, Suzuki O, Ambo Y, Nakamura F, Kishida A (2013) Triclosan-coated sutures reduce the incidence of wound infections and the costs after colorectal surgery: a randomized controlled trial. Surgery 153:576–583. doi:10.1016/j.surg.2012.11.018
Justinger C, Slotta JE, Ningel S, Gräber S, Kollmar O, Schilling MK (2013) Surgical-site infection after abdominal wall closure with triclosan-impregnated polydioxanone sutures: results of a randomized clinical pathway facilitated trial (NCT00998907). Surgery 154:589–595. doi:10.1016/j.surg.2013.04.011
Hoshino S, Yoshida Y, Tanimura S, Yamauchi Y, Noritomi T, Yamashita Y (2013) A study of the efficacy of antibacterial sutures for surgical site infection: a retrospective controlled trial. Int Surg 98:129–132. doi:10.9738/CC179
Turtiainen J, Saimanen EI, Makinen KT, Nykanen AI, Venermo MA, Uurto IT, Hakala T (2012) Effect of triclosan-coated sutures on the incidence of surgical wound infection after lower limb revascularization surgery: a randomized controlled trial. World J Surg 36:2528–2534. doi:10.1007/s00268-012-1655-4
Seim BE, Tønnessen T, Woldbaek PR (2012) Triclosan-coated sutures do not reduce leg wound infections after coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 15:411–415. doi:10.1093/icvts/ivs266
Laas E, Poilroux C, Bezu C, Coutant C, Uzan S, Rouzier R, Chereau E (2012) Antibacterial-coated suture in reducing surgical site infection in breast surgery: a prospective study. Int J Breast Cancer 2012:819578. doi:10.1155/2012/819578
Isik I, Selimen D, Senay S, Alhan C (2012) Efficiency of antibacterial suture material in cardiac surgery: a double-blind randomized prospective study. Heart Surg Forum 15:E40–E45. doi:10.1532/HSF98.20111106
Williams N, Sweetland H, Goyal S, Ivins N, Leaper DJ (2011) Randomized trial of antimicrobial-coated sutures to prevent surgical site infection after breast cancer surgery. Surg Infect 12:469–474. doi:10.1089/sur.2011.045
Rasic Z, Schwarz D, Adam VN, Sever M, Lojo N, Rasic D, Matejic T (2011) Efficacy of antimicrobial triclosan-coated polyglactin 910 (Vicryl* Plus) suture for closure of the abdominal wall after colorectal surgery. Coll Antropol 35:439–443
Galal I, El-Hindawy K (2011) Impact of using triclosan-antibacterial sutures on incidence of surgical site infection. Am J Surg 202:133–138. doi:10.1016/j.amjsurg.2010.06.011
Chen SY, Chen TM, Dai NT, Fu JP, Chang SC, Deng SC, Chen SG (2011) Do antibacterial-coated sutures reduce wound infection in head and neck cancer reconstruction? Eur J Surg Oncol 37:300–304. doi:10.1016/j.ejso.2011.01.015
Baracs J, Huszar O, Sajjadi SG, Horvath OP (2011) Surgical site infections after abdominal closure in colorectal surgery using triclosan-coated absorbable suture (PDS Plus) vs. uncoated sutures (PDS II): a randomized multicenter study. Surg Infect 12:483–489. doi:10.1089/sur.2011.001
Mingmalairak C, Ungbhakorn P, Paocharoen V (2009) Efficacy of antimicrobial coating suture coated polyglactin 910 with tricosan (Vicryl plus) compared with polyglactin 910 (Vicryl) in reduced surgical site infection of appendicitis, double blind randomized control trial, preliminary safety report. J Med Assoc Thail 92:770–775
Ford HR, Jones P, Gaines B, Reblock K, Simpkins DL (2005) Intraoperative handling and wound healing: controlled clinical trial comparing coated VICRYL plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated VICRYL suture (coated polyglactin 910 suture). Surg Infect 6:313–321. doi:10.1089/sur.2005.6.313
Fleck T, Moidl R, Blacky A, Fleck M, Wolner E, Grabenwoger M, Wisser W (2007) Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg 84:232–236. doi:10.1016/j.athoracsur.2007.03.045
Edminston CE, Seabrook GR, Goheen MP, Krepel CJ, Johnson CP, Lewis BD, Brown KR, Towne JB (2006) Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination? J Am Coll Surg 203:481–489. doi:10.1016/j.jamcollsurg.2006.06.026
Ming X, Nichols M, Rothenburger S (2007) In vivo antibacterial efficacy of MONOCRYL plus antibacterial suture (Poliglecaprone 25 with triclosan). Surg Infect 8:209–214. doi:10.1089/sur.2006.004
Deliaert AE, Van den Kerckhove E, Tuinder S, Fieuws S, Sawor JH, Meesters-Caberg MA, van der Hulst RR (2009) The effect of triclosan-coated sutures in wound healing. A double blind randomised prospective pilot study. J Plast Reconstr Aesthet Surg 62:771–773. doi:10.1016/j.bjps.2007.10.075
Bhutani T, Jacob SE (2009) Triclosan: a potential allergen in suture-line allergic contact dermatitis. Dermatol Surg 35:888–889. doi:10.1111/j.1524-4725.2009.01151.x
Chang WK, Srinivasa S, Morton R, Hill AG (2012) Triclosan-impregnated sutures to decrease surgical site infections: systematic review and meta-analysis of randomized trials. Ann Surg 255:854–859. doi:10.1097/SLA.0b013e31824e7005
Wang ZX, Jiang CP, Cao Y, Ding YT (2013) Systematic review and meta-analysis of triclosan-coated sutures for the prevention of surgical-site infection. Br J Surg 100:465–473. doi:10.1002/bjs.9062
Edmiston CE Jr, Daoud FC, Leaper D (2013) Is there an evidence-based argument for embracing an antimicrobial (triclosan)-coated suture technology to reduce the risk for surgical-site infections?: A meta-analysis. Surgery 154:89–100. doi:10.1016/j.surg.2013.03.008
Sajid MS, Craciunas L, Sains P, Singh KK, Baig MK (2013) Use of antibacterial sutures for skin closure in controlling surgical site infections: a systematic review of published randomized, controlled trials. Gastroenterol Rep (Oxf) 1:42–50. doi:10.1093/gastro/got003
Daoud FC, Edmiston CE Jr, Leaper D (2014) Meta-analysis of prevention of surgical site infections following incision closure with triclosan-coated sutures: robustness to new evidence. Surg Infect 15:165–181. doi:10.1089/sur.2013.177
Guo J, Pan LH, Li YX, Yang XD, Li LQ, Zhang CY, Zhong JH (2016) Efficacy of triclosan-coated sutures for reducing risk of surgical site infection in adults: a meta-analysis of randomized clinical trials. J Surg Res 201:105–117. doi:10.1016/j.jss.2015.10.015
Rozzelle CJ, Leonardo J, Li V (2008) Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr 2:111–117. doi:10.3171/PED/2008/2/8/111
Meintjes J, Yan S, Zhou L, Zheng S, Zheng M (2011) Synthetic, biological and composite scaffolds for abdominal wall reconstruction. Expert Rev Med Devices 8:275–288. doi:10.1586/erd.10.64
Nagaty AM, Nayel S, Taher I, Beddewy M (2005) Episiotomy repair different suture materials and different techniques. Bull Alex Fac Med 41:377–389
Fraccalvieri D, Kreisler Moreno E, Flor Lorente B, Torres Garcia A, Munoz Calero A, Mateo Vallejo F, Biondo S (2014) Predictors of wound infection in elective colorectal surgery. Multicenter observational case–control study. Cir Esp 92:478–484. doi:10.1016/j.ciresp.2013.07.017
Justinger C, Moussavian MR, Schlueter C, Kopp B, Kollmar O, Schilling MK (2009) Antibacterial [corrected] coating of abdominal closure sutures and wound infection. Surgery 145:330–334. doi:10.1016/j.surg.2008.11.007
Zhang ZT, Zhang HW, Fang XD, Wang LM, Li XX, Li YF, Sun XW, Carver J, Simpkins D, Shen J, Weisberg M (2011) Cosmetic outcome and surgical site infection rates of antibacterial absorbable (Polyglactin 910) suture compared to Chinese silk suture in breast cancer surgery: a randomized pilot research. Chin Med J 124:719–724
DeFazio A, Datta MS, Nezhat C (2005) Does the use of Vicryl Plus antibacterial suture decrease the incidence of umbilical infection when compared to Vicryl suture? Fertil Steril 84(Suppl 1):S161
Singh H, Emmert MY, Sakaguchi H, Neng Lee C, Kofidis T (2010) Antibacterial suture reduces surgical site infections in coronary artery bypass grafting. Heart Surg Forum 13:S85
Khachatryan N, Dibirov M, Omelyanovsky V, Chupalov M, Gasanova G (2011) Prevention of postoperative infections in abdominal surgery using reabsorbable suture with antibacterial activity (vicryl plus) versus reabsorbable standard sutures. Surg Infect 12:A13–A14
Zhuang CP, Cai GY, Wang YQ (2009) Comparison of two absorbable sutures in abdominal wall incision. J Clin Rehabilitative Tissue Eng Res 13:4045–4048
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
None.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
Not applicable.
Informed consent
Not applicable.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 210 kb)
Rights and permissions
About this article
Cite this article
Wu, X., Kubilay, N.Z., Ren, J. et al. Antimicrobial-coated sutures to decrease surgical site infections: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis 36, 19–32 (2017). https://doi.org/10.1007/s10096-016-2765-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-016-2765-y